Trius Therapeutics, Inc. (TSRX) Posts Q2 Loss of 41c/Share
Tweet Send to a Friend
Trius Therapeutics, Inc. (NASDAQ: TSRX) reported Q2 EPS of ($0.41) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
